Using the Mirena intrauterine system to treat severe primary dysmenorrhoea in an adolescent
Williamson, M.; Bulmer, P.
Journal of Obstetrics and Gynaecology the Journal of the Institute of Obstetrics and Gynaecology 30(2): 206-207
2010
ISSN/ISBN: 1364-6893 PMID: 20143992 DOI: 10.3109/01443610903452773Document Number: 210400
Document emailed within 0-6 h
Related Documents
Wong, A.Y.K.; Tang, L.C.H.; Chin, R.K.H. 2010: Levonorgestrel-releasing intrauterine system (Mirena) and Depot medroxyprogesterone acetate (Depoprovera) as long-term maintenance therapy for patients with moderate and severe endometriosis: a randomised controlled trial Australian and New Zealand Journal of Obstetrics and Gynaecology 50(3): 273-279Ng, Y.W.; Liang, S.; Singh, K. 2009: Effects of Mirena (levonorgestrel-releasing intrauterine system) and Ortho Gynae T380 intrauterine copper device on lipid metabolism--a randomized comparative study Contraception 79(1): 24-28
Charlton, F.; Otton, G.; Hedges, A.; Scurry, J. 2014: Endometrial granulomas with Levonorgestrel Intrauterine System (Mirena) Pathology 46(5): 457-458
Shaamash, A.H.; Sayed, G.H.; Hussien, M.M.; Shaaban, M.M. 2005: A comparative study of the levonorgestrel-releasing intrauterine system Mirena® versus the Copper T380A intrauterine device during lactation : breast-feeding performance, infant growth and infant development Contraception (Stoneham) 72(5): 346-351
Shaamash, A.H.; Sayed, G.H.; Hussien, M.M.; Shaaban, M.M. 2005: A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development Contraception 72(5): 346-351
Silva, C.D.; Geraldes, F.; Silva, I.S. 2013: Levonorgestrel intrauterine system as a treatment option for severe menorrhagia in adolescent with type IIi von Willebrand disease BMJ Case Reports
Peng, F.-S.; Wu, M.-Y.; Yang, J.-H.; Chen, S.-U.; Ho, H.-N.; Yang, Y.-S. 2010: Insertion of the Mirena intrauterine system for treatment of adenomyosis-associated menorrhagia: a novel method Taiwanese Journal of Obstetrics and Gynecology 49(2): 160-164
Hidalgo, M.; Bahamondes, L.; Perrotti, M.; Diaz, J.; Dantas-Monteiro, C.; Petta, C. 2002: Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years Contraception 65(2): 129-132
Chen, X.; Wu, X.; Zhu, H. 2014: Acute urticaria as a side effect of the Mirena® (levonorgestrel-releasing intrauterine system): a case report Bmc Research Notes 7: 209
Jóźwik, M.; Jóźwik, M.; Modzelewska, B.; Niewińska, M.; Jóźwik, Mł. 2015: Levonorgestrel-releasing intrauterine system Mirena® (Bayer) for the prevention and treatment of endometrial adenocarcinoma and the incidence of other malignancies in women Ginekologia Polska 86(4): 305-310
Marshall, M.; Jordan, K.; Brand, J.L.; Welborn, T.L. 2013: In women over 35 years of age who smoke, does mirena (levonorgestrel-releasing intrauterine system) reduce the risk of DVTs compared to oral contraceptives? Journal of the Oklahoma State Medical Association 106(9): 362-363
Herman, M.C.; van den Brink, M.J.; Geomini, P.M.; van Meurs, H.S.; Huirne, J.A.; Eising, H.P.; Timmermans, A.; Pijnenborg, J.M.A.; Klinkert, E.R.; Coppus, S.F.; Nieboer, T.E.; Catshoek, R.; van der Voet, L.F.; van Eijndhoven, H.W.F.; Graziosi, G.C.M.; Veersema, S.; van Kesteren, P.J.; Langenveld, J.; Smeets, N.A.C.; van Vliet, H.A.A.M.; van der Steeg, J.W.; Lisman-van Leeuwen, Y.; Dekker, J.H.; Mol, B.W.; Berger, M.Y.; Bongers, M.Y. 2013: Levonorgestrel releasing intrauterine system (Mirena) versus endometrial ablation (Novasure) in women with heavy menstrual bleeding: a multicentre randomised controlled trial Bmc Women's Health 13: 32
Strowitzki, T.; Kirsch, B.; Elliesen, J.ör. 2012: Efficacy of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen in women with moderate-to-severe primary dysmenorrhoea: an open-label, multicentre, randomised, controlled study Journal of Family Planning and Reproductive Health Care 38(2): 94-101
Harrison-Woolrych, M.; Zhou, L.; Coulter, D. 2003: Insertion of intrauterine devices: a comparison of experience with Mirena and Multiload Cu 375 during post-marketing monitoring in New Zealand New Zealand Medical Journal 116(1179): U538
Vaughan, D.; Byrne, P. 2012: An evaluation of the simultaneous use of the levonorgestrel-releasing intrauterine device (LNG-IUS, Mirena®) combined with endometrial ablation in the management of menorrhagia Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 32(4): 372-374
Gokhale, L.B. 1996: Curative treatment of primary (spasmodic) dysmenorrhoea Indian Journal of Medical Research 103: 227-231
McGarry, J. 1983: Inhibitors of prostaglandin synthesis and primary dysmenorrhoea British Journal of Clinical Practice 37(5): 195
Wong, C.L.; Farquhar, C.; Roberts, H.; Proctor, M. 2009: Oral contraceptive pill as treatment for primary dysmenorrhoea Cochrane Database of Systematic Reviews 2: Cd002120
McGavigan, C.Jay.; Cameron, I.T. 2003: The Mirena levonorgestrel system Drugs of Today 39(12): 973-984
Akerlund, M.; Melin, P.; Maggi, M. 1995: Potential use of oxytocin and vasopressin V1a antagonists in the treatment of preterm labour and primary dysmenorrhoea Advances in Experimental Medicine and Biology 395: 595-600